Mar 16, 2017 11:30 am UTC| Business
− Overall Response Rate of 28.4% Observed in Phase 2b SADAL Study in Relapsed/Refractory DLBCL; Additional Top-line Data to be Presented as a Late-Breaker at AACR 2017 Annual Meeting – − Company Announces FDA-Affirmed...
Houston Wire & Cable Company Reports Results for the Quarter Ended December 31, 2016
Mar 16, 2017 11:30 am UTC| Business
HOUSTON, March 16, 2017 -- Houston Wire Cable Company (NASDAQ:HWCC) (the “Company”) announced operating results for the fourth quarter and year ended December 31, 2016. Selected quarterly results were:Sales of $69.3...
Trans World Entertainment Announces Annual and Fourth Quarter Results
Mar 16, 2017 11:30 am UTC| Business
ALBANY, N.Y., March 16, 2017 -- Trans World Entertainment Corporation (Nasdaq:TWMC) today reported financial results for the 13 (“Fourth Quarter”) and 52 week periods (“Fiscal 2016”) ended January 28, 2017. “Our...
Stein Mart to Present at Sidoti & Company Spring 2017 Convention
Mar 16, 2017 11:30 am UTC| Business
JACKSONVILLE, Fla., March 16, 2017 -- Stein Mart, Inc. (NASDAQ:SMRT) announced today that it will be presenting at the Sidoti Company Spring 2017 Convention being held at the Marriott Marquis at Times Square in New...
T-Mobile US, Inc. to Present at the Citi European & Emerging Telecoms Conference in London, GB
Mar 16, 2017 11:30 am UTC| Business
BELLEVUE, Wash., March 16, 2017 -- Neville Ray, Executive Vice President Chief Technology Officer, and Nils Paellmann, Vice President Head of Investor Relations of T-Mobile US, Inc. (NASDAQ:TMUS) will present and...
Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use Nationwide
Mar 16, 2017 11:30 am UTC| Business
PARSIPPANY, N. J. and LIVONIA, Mich., March 16, 2017 -- Trinity Health, one of the largest hospital systems in the nation, and Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), today announced they will collaborate to develop...
Mar 16, 2017 11:30 am UTC| Business
Poster Presentations Highlight Oral Equivalency and Intranasal Abuse Deterrence Technology CORALVILLE, Iowa, March 16, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on...
Trump's Hammer on Russian Oil Buyers: 500% Tariffs Loom